TY - JOUR
KW - Biomedical Engineering
KW - Experimental models of disease
KW - policy
AU - Samantha G. Zambuto
AU - Adrienne K. Scott
AU - Michelle L. Oyen
AB - The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.
BT - Nature Reviews Bioengineering
DA - 2024-12
DO - 10.1038/s44222-024-00252-8
IS - 12
LA - en
N2 - The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.
PY - 2024
SP - 984
EP - 986
T2 - Nature Reviews Bioengineering
TI - FDA Modernization Act 2.0 and reproductive research
UR - https://www.nature.com/articles/s44222-024-00252-8
VL - 2
Y2 - 2026-08-12
SN - 2731-6092
ER -